John Kyung Lee, MD
University of California, Los Angeles
2015
$
100000
Irving Feintech Family Foundation Research Grant
Targeting Myc Oncoproteins in Advanced Prostate Cancer
Advanced prostate cancer is a deadly disease with limited treatment options. Two members of the Myc family of cancer genes named c-Myc and N-Myc are active in the main types of lethal prostate cancer – castration-resistant prostate adenocarcinoma and small cell neuroendocrine prostate cancer. In this work, Dr. Lee will clarify the biologic functions of c-Myc and N-Myc in two unique prostate cancer models developed from normal human prostates. Dr. Lee will take advantage of these models of advanced prostate cancer to find new therapies and evaluate a promising inhibitor that directly targets the activity of N-Myc in cancer cells.
Support the Journey
When you donate to Tower, you’re not supporting a single study. You’re part of an ecosystem that believes the next breakthrough is out there, waiting for someone to believe in it first. Every gift puts resources directly behind the discoveries that would otherwise never see the light of day.